Session 23
OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France
< back to Program at a glance
< back to all the scientific sessions
Session 23: Esophageal Cancer: Adenocarcinoma
Thursday, April 25, 4:00 – 5:30 pm
Auditorium Kagame
Introduction: Arnulf Hölscher (Germany)
«In memoriam Professor Dr. Jörg Rüdiger Siewert – Vita and SIEWERT classification»
«In memoriam Professor Dr. Jörg Rüdiger Siewert – Vita and SIEWERT classification»
Chairs: Stefan P. Mönig (Switzerland) – Giovanni de Manzoni (Italy)
Moderators: Arnulf Hölscher (Germany) – Bruno Zilberstein (Brazil) – Edward Cheong Chee Keong (Singapore) – Marc van Berge Hennegouwen (Netherlands)
- Decision making in Siewert II Adenocarcinoma: gastrectomy versus esophagectomy? – Stefan P. Mönig (Switzerland)
- Is thoracic duct resection indicated in adenocarcinoma of the esophagus? – Paolo Morgagni (Italy)
- Lymph node dissection of the upper mediastinum – indicated in all patients? – Paul M. Schneider (Switzerland)
- Which is the evidence-based surgical approach: transhiatal, left thoracoabdominal, two-stage transthoracic or three-stage transthoracic for distal esophageal adenocarcinoma? – Andrew Davis (UK)
- F Is cT1 still a surgical disease, and in which cases? – Maria Bencivenga (Italy)
- What is the best way to treat anastomotic leakage: intrathoracic anastomosis? – Marc van Berge Hennegouwen (Netherlands)